Dilbro UniCap Inhalation Capsule 110 mcg+50 mcg contains a combination of Indacaterol 110 mcg and Glycopyrronium 50 mcg, formulated for the management of chronic obstructive pulmonary disease (COPD). This dual therapy combines a long-acting beta-2 agonist (LABA) and a long-acting muscarinic antagonist (LAMA), offering complementary bronchodilation for improved lung function and symptom control in patients with moderate to severe COPD.

COPD is a progressive lung disorder characterized by airflow limitation, chronic inflammation, breathlessness, cough, and frequent exacerbations. Dilbro UniCap works by relaxing airway smooth muscles, reducing airway resistance, and improving airflow, thereby reducing breathlessness and enhancing exercise tolerance. The combination of Indacaterol and Glycopyrronium ensures once-daily, long-lasting bronchodilation, allowing patients to maintain better control over their daily activities.

The inhalation capsule format ensures direct delivery of medication to the lungs, providing rapid onset of action and reducing systemic exposure compared to oral medications. It is ideal for patients seeking effective symptom relief with a convenient once-daily dosing regimen.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Dilbro UniCap Inhalation Capsule 110 mcg+50 mcg is indicated for:

• Maintenance treatment of moderate to severe COPD

• Reduction of dyspnea (shortness of breath) in COPD patients

• Improvement of lung function, exercise capacity, and quality of life

• Prevention of COPD exacerbations when used as part of a long-term management plan

Key Benefits

• Provides dual bronchodilation through LABA and LAMA combination

• Improves airflow, lung function, and exercise tolerance

• Reduces shortness of breath and breathlessness during daily activities

• Convenient once-daily dosing enhances patient adherence

• Direct inhalation delivery ensures faster symptom relief and lower systemic side effects

Mechanism of Action

• Indacaterol (110 mcg) is a long-acting beta-2 adrenergic receptor agonist (LABA). It relaxes airway smooth muscles by stimulating beta-2 receptors, leading to bronchodilation and improved airflow.

• Glycopyrronium (50 mcg) is a long-acting muscarinic antagonist (LAMA) that blocks acetylcholine at muscarinic receptors in the airways, preventing bronchoconstriction and reducing mucus secretion.

Together, these agents provide synergistic bronchodilation, targeting different pathways to enhance airflow, reduce hyperinflation, and improve overall lung function in COPD patients.

Dosage and Administration

• One capsule inhaled once daily using a suitable dry powder inhaler (DPI).

• Do not swallow the capsule; it must be inhaled using the prescribed inhaler device.

• Take at the same time every day to maintain consistent therapeutic effect.

• Do not use more than the recommended dose.

Precautions

• Not recommended for acute bronchospasm or asthma attacks; this is for maintenance therapy only.

• Use cautiously in patients with cardiovascular disease, glaucoma, or urinary retention.

• Inform the physician about all other medications to avoid drug interactions.

• Seek medical attention if experiencing severe palpitations, chest pain, or difficulty breathing.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Dilbro UniCap Inhalation Capsule 110 mcg+50 mcg is generally well tolerated. Side effects may include:

• Dry mouth

• Cough or throat irritation

• Headache

• Palpitations or mild tremors

• Rarely, urinary retention or blurred vision

Most side effects are mild and resolve with continued use.

Storage

Store below 30°C in a dry, cool place, away from moisture and direct sunlight. Keep out of reach of children.